Prime Medicine, Inc. (PRME)

NGM – Real Time Price. Currency in USD

3.30

+0.06 (1.85%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-7M

-6M

-5M

-12M

Gross Profit

-3M

-5M

-12M

Operating expenses (excl. COGS)

-206M

-199M

-187M

-105M

Operating Income

-208M

-202M

-191M

-117M

Non-operating income, total

-7M

-6M

Pretax income

-201M

-196M

-198M

-123M

Equity in earnings

Taxes

279K

948K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-201M

-196M

-198M

-122M

Prime Medicine, Inc. (PRME)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Prime Medicine, Inc. (PRME)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Prime Medicine, Inc. (PRME)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Prime Medicine, Inc. (PRME)

Income Statement (Annual)

Income Statement (Annual)